#glp-1-receptor-agonists

[ follow ]
#weight-loss
Medicine
fromwww.theguardian.com
11 months ago

Women advised to pair effective contraception with skinny jabs'

Experts warn that the use of medications like Wegovy and Ozempic, popular for weight loss, may inadvertently lead to unexpected pregnancies due to improved fertility in women with obesity.
Wearables
fromNew York Post
1 week ago

Eli Lilly stock surges 15% after clinical trial of weight loss pill shows it works like Ozempic

Eli Lilly's orforglipron shows significant weight loss for Type 2 diabetes patients, potentially rivaling injectable medications.
Lilly's shares surged 15% following promising clinical trial results for orforglipron.
fromtime.com
3 months ago
Medicine

The Health Risks and Benefits of Weight-Loss Drugs

GLP-1 receptor agonists not only aid in weight loss but also influence various health conditions positively and negatively.
fromNature
3 months ago
Medicine

Obesity drugs: huge study highlights new health risks

GLP-1 receptor agonists have significant benefits for weight loss and other conditions but also present risks like arthritis and pancreatitis.
fromHarvard Gazette
8 months ago
Medicine

Should young bariatric surgery patients use weight-loss drugs? - Harvard Gazette

The use of GLP-1 receptor agonists in adolescents warrants closer examination due to limited research and safety concerns compared to their use in adults.
Medicine
fromwww.theguardian.com
11 months ago

Women advised to pair effective contraception with skinny jabs'

Experts warn that the use of medications like Wegovy and Ozempic, popular for weight loss, may inadvertently lead to unexpected pregnancies due to improved fertility in women with obesity.
Wearables
fromNew York Post
1 week ago

Eli Lilly stock surges 15% after clinical trial of weight loss pill shows it works like Ozempic

Eli Lilly's orforglipron shows significant weight loss for Type 2 diabetes patients, potentially rivaling injectable medications.
Lilly's shares surged 15% following promising clinical trial results for orforglipron.
fromtime.com
3 months ago
Medicine

The Health Risks and Benefits of Weight-Loss Drugs

GLP-1 receptor agonists not only aid in weight loss but also influence various health conditions positively and negatively.
fromNature
3 months ago
Medicine

Obesity drugs: huge study highlights new health risks

GLP-1 receptor agonists have significant benefits for weight loss and other conditions but also present risks like arthritis and pancreatitis.
fromHarvard Gazette
8 months ago
Medicine

Should young bariatric surgery patients use weight-loss drugs? - Harvard Gazette

The use of GLP-1 receptor agonists in adolescents warrants closer examination due to limited research and safety concerns compared to their use in adults.
more#weight-loss
Mental health
fromPsychology Today
1 month ago

The Psychology of Addiction and Obesity: New Treatments

Addiction and obesity share neurological pathways, reinforcing compulsive behaviors.
GLP-1 receptor agonists may help regulate both appetite and addictive cravings.
Emerging compounds, such as MEAI, are being studied for its potential in addiction treatment.
A holistic approach combining therapy, medication, and new research offers hope.
#obesity-treatment
US news
fromBoston.com
2 months ago

Could obesity drugs help with alcohol cravings? New study suggests potential

GLP-1 receptor agonists show potential in reducing alcohol cravings but safety for non-obese individuals remains uncertain.
fromenglish.elpais.com
1 year ago
OMG science

Diabetes drugs test a new side effect: slowing down symptoms of Parkinson's

GLP-1 receptor agonists have potential benefits beyond just treating diabetes and obesity, potentially impacting diseases like Alzheimer's and Parkinson's positively.
US news
fromBoston.com
2 months ago

Could obesity drugs help with alcohol cravings? New study suggests potential

GLP-1 receptor agonists show potential in reducing alcohol cravings but safety for non-obese individuals remains uncertain.
fromenglish.elpais.com
1 year ago
OMG science

Diabetes drugs test a new side effect: slowing down symptoms of Parkinson's

GLP-1 receptor agonists have potential benefits beyond just treating diabetes and obesity, potentially impacting diseases like Alzheimer's and Parkinson's positively.
more#obesity-treatment
Medicine
fromwww.theguardian.com
5 months ago

Weight-loss drugs can improve kidney health, study finds

GLP-1 receptor agonists significantly lower the risk of kidney failure, worsening kidney function, and death due to kidney disease by approximately 19%.
[ Load more ]